Safety and Efficacy of Therapeutic Angiogenesis as a Novel Treatment in Patients with Critical Limb Ischemia

Annals of Vascular Surgery

Volumn 24, Issue 2, 2010, Pages 287-294

  Lara Hernandez, R ^a   Lozano Vilardell, P ^a   Blanes, P ^a   Torreguitart Mirada, N ^a   Galmes A ^a   Besalduch, J ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ANGIOGENESIS; ANKLE BRACHIAL INDEX; APHERESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LIMB AMPUTATION; LIMB ISCHEMIA; LIMB SALVAGE; MALE; PAIN ASSESSMENT; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RISK ASSESSMENT; STEM CELL TRANSPLANTATION; ULCER HEALING;

ADULT; AGED; AMPUTATION; ANKLE BRACHIAL INDEX; BLOOD COMPONENT REMOVAL; CELL MOVEMENT; CRITICAL ILLNESS; ENDOTHELIAL CELLS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; ISCHEMIA; KAPLAN-MEIERS ESTIMATE; LOWER EXTREMITY; MALE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; PAIN; PAIN MEASUREMENT; PHOTOPLETHYSMOGRAPHY; PILOT PROJECTS; PROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER; WOUND HEALING; YOUNG ADULT;

EID: 75149117762     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.avsg.2009.10.012     Document Type: Article

References (40)

1. Dormandy J., Mahir M., Ascady G., et al. Fate of the patient with chronic leg ischaemia. A review article. J Cardiovasc Surg 30 (1989) 50-57
2. Lozano-Vilardell P., Corominas-Roura C., Gomez-Ruiz F.T., Manuel-Rimbau E., and Juliá-Montoya J. Evolución natural de la isquemia crítica de los miembros inferiores. Angiología 55 Suppl. 1 (2003) S38-S46
3. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 33 (2007) S5-S75
4. Wolfe J.H., and Wyatt M.G. Critical and subcritical ischaemia. Eur J Vasc Endovasc Surg 13 (1997) 578-582
5. Risau W., Sariola H., Zerwes H.G., et al. Vasculogenesis and angiogenesis in embryonic stem-cell-derived embryoid bodies. Development 102 (1988) 471
6. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 285 (1971) 1182
7. Oren M., Tepper B.A., Galiano R.D., Kalka C., and Gurtner G.C. Endothelial progenitor cells: the promise of vascular stem cells for plastic surgery. Plast Reconstr Surg 111 (2003) 846-854
8. Collinson D.J., and Donnelly R. Therapeutic angiogenesis in peripheral arterial disease: can biotechnology produce an effective collateral circulation?. Eur J Vasc Endovasc Surg 28 (2004) 9-23
9. Yoshida W.B. Angiogenesis, arteriogenesis and vasculogenesis: treatment of the future for lower limb critical ischemia?. Braz Vasc J. 4 (2005) 209-211
10. Lederman R.J., Mendelsohn F., Anderson R.D., et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomized trial. Lancet 359 (2002) 2053-2058
11. Rajagopalan S., Mohler E., Lederman R.J., et al. Regional angiogenesis with vascular endothelial growth factor (VEGF) in peripheral arterial disease: design of the RAVE trial. Am Heart J 145 (2003) 1114-1118
12. Baffour R., Berman J., Garb J., Rhee S., Kaufman J., and Friedmann P. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant bFGF in a rat model of acute lower limb ischaemia: dose response effect of bFGF. J Vasc Surg 2 (1992) 181-191
13. Morishita R., Nakamura S., Hayashi S., et al. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in a rabbit hind limb ischaemia model as cytokine supplement therapy. Hypertension 33 (1999) 1379-1384
14. Henry T., Rocha-Singh K., Isner J., et al. Intracoronary administration of recombinant human VEGF to patients with coronary artery disease. Am Heart J 142 (2001) 872-880
15. Henry T., Annex B., McKendall G., et al. The VIVA trial: VEGF in Ischaemia for Vascular Angiogenesis. Circulation 107 (2003) 1359-1365
16. Cooper L., Hiatt W., Creager M., et al. Proteinuria in a placebo-controlled study of bFGF for intermittent claudication. Vasc Med 6 (2001) 235-239
17. Reyes M., Dudek A., Jahagirdar B., Koodie L., Marker P.H., and Verfaillie C.M. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109 (2002) 337-346
18. Kalka C., Masuda H., Takahashi T., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97 (2000) 3422-3427
19. Kinnaird T., Stabile E., Burnett M.S., and Epstein S.E. Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences. Circ Res. 95 (2004) 354-363
20. Zammaretti P., and Zisch A.H. Adult endothelial progenitor cells. Renewing vasculature. Int J Biochem Cell Biol 37 (2005) 493-503
21. Fadini G.P., Miorin M., Facco M., et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 45 (2005) 1449-1457
22. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function and cardiovascular risk. N Engl J Med 348 (2003) 593-600
23. Vasa M., Fichtlscherer S., Adler K., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 89 (2001) 1-7
24. Al-Khaldi A., Al-Sabti H., Galipeau J., and Lachapelle K. Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model. Ann Thorac Surg 75 (2003) 204-209
25. Iba O., Matsubara H., Nozawa Y., et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 106 (2002) 2019-2025
26. Tan Y., Shao H., Eton D., et al. Stromal cell-derived factor-1 enhances pro-angiogenic effect of granulocyte-colony stimulating factor. Cardiovasc Res 73 (2007) 823-832
27. - mononuclear cells. Thromb Haemost 95 (2006) 301-311
28. Tateishi-Yuyama E., Matsubara H., Murohara T., et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360 (2002) 427-435
29. Higashi Y., Kimura M., Hara K., et al. Autologous bone-marrow cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia. Circulation 109 (2004) 1215-1218
30. Esato K., Hamano K., Li T.S., et al. Neovascularization induced by autologous bone marrow cell implantation in peripheral arterial disease. Cell Transplant 11 (2002) 747-752
31. Durdu S., Akar A.R., Arat M., Sancak T., Eren N.T., and Ozyurda U. Autologous bone-marrow mononuclear cell implantation for patients with rutherford grade II-III thromboangiitis obliterans. J Vasc Surg 44 (2006) 732-739
32. Huang P., Li S., Han M., Xiao Z., Yang R., and Han Z.C. Autologous transplantation of granulocyte colony-stimulating factor mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care 28 (2005) 2155-2160
33. Ishida A., Ohya Y., Sakuda H., et al. Autologous peripheral blood mononuclear cell implantation for patients with peripheral arterial disease improves limb ischemia. Circ J 69 (2005) 1260-1265
34. Korbling M., Reuben J.M., Gao H., et al. Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis. Transfusion 46 (2006) 1795-1802
35. Kawamura A., Horie T., Tsuda I., et al. Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell transplantation in 92 patients with critically ischemic limbs. J Artif Organs 9 (2006) 226-233
36. Yoshida M., Horimoto H., Mieno S., et al. Intra-arterial bone marrow cell transplantation induces angiogenesis in rat hindlimb ischemia. Eur Surg Res 35 (2003) 86-91
37. Hirsch A., Nijveldt R., van der Vleuten P.A., et al. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial-a prospective, multicenter randomized trial. Am Heart J 152 (2006) 434-441
38. Morgan M.B., Crayford T., Murrin B., and Fraser S.C. Developing the Vascular Quality of Life Questionnaire: a new disease-specific quality of life measure for use in lower limb ischemia. J Vasc Surg 33 (2001) 679-687
39. Boonstra A.M., Schiphorst Preuper H.R., Reneman M.F., Posthumus J.B., and Stewart R.E. Reliability and validity of the visual analogue scale for disability in patients with chronic musculoskeletal pain. Int J Rehabil Res 31 (2008) 165-169
40. Takeshita S., Isshiki T., Mori H., et al. Use of synchrotron radiation microangiography to assess development of small collateral arteries in a rat model of hindlimb ischemia. Circulation 95 (1997) 805-808